Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T
First Department of Internal Medicine, Miyazaki Medical College, Japan.
Am J Kidney Dis. 1998 Jun;31(6):991-6. doi: 10.1053/ajkd.1998.v31.pm9631844.
We retrospectively investigated the incidence and prognosis of and risk factors for cerebrovascular events in 1,064 patients with chronic uremia who received maintenance hemodialysis (HD) for more than 3 months during 24 years in our dialysis units in Miyazaki, Japan. Cerebrovascular events developed in 98 patients (9.2%). The confirmed incidences of cerebral hemorrhage (CH) and infarction were 8.7 and 3.7 per 1,000 patient-years, respectively. Of the 56 patients with CH, 40 (71.4%) died within 3 months of the onset of CH. Ganglio-thalamic lesion was observed in 32 (80.0%) of 40 patients with CH confirmed by a brain computed tomography. The incidence of polycystic kidney disease was higher in the CH group than in the overall HD population (12.5% v 3.9%, P < 0.01). Of the 13 patients with diabetes mellitus and nephrosclerosis, nine (69.2%) developed CH within 36 months of the initiation of HD; 11 (78.6%) of 14 patients with chronic glomerulonephritis developed CH after 36 months. CH developed in six patients (15.0%) within 6 hours of a previous HD session. We compared laboratory values, the supine blood pressure, and electrocardiographic (ECG) findings in 35 patients with CH and a control group (66 patients) matched in age, sex, basal renal disease, age at the initiation of HD, and the duration of HD. Data were obtained before and after HD 3 to 4 months before the first attack of CH. The systolic and diastolic blood pressure (SBP, DBP) before and after HD were significantly higher in the CH group than in the control group (pre-HD SBP: 171 +/- 22.5 v 154 +/- 19.3 mm Hg, P < 0.001; pre-HD DBP: 89 +/- 13.6 v 81 +/- 9.6 mm Hg, P < 0.001). The incidence of left ventricular hypertrophy was higher, and the Kt/V was significantly lower (1.23 +/- 0.26 v 1.38 +/- 0.34, P < 0.05) in the CH group than in the control group. However, there were no significant differences in the serum levels of albumin and cholesterol or the total dose of heparin during HD sessions between groups. In conclusion, the incidence of CH was high, and its prognosis was poor, in patients undergoing maintenance HD. Reversible risk factors include hypertension and possibly the amount of HD prescribed, but not anticoagulation with heparin.
我们回顾性调查了日本宫崎我们透析中心24年间接受维持性血液透析(HD)3个月以上的1064例慢性尿毒症患者脑血管事件的发生率、预后及危险因素。98例患者(9.2%)发生了脑血管事件。脑出血(CH)和梗死的确诊发病率分别为每1000患者年8.7例和3.7例。56例CH患者中,40例(71.4%)在CH发病后3个月内死亡。40例经脑计算机断层扫描确诊的CH患者中,32例(80.0%)观察到丘脑底节病变。CH组多囊肾病的发生率高于总体HD人群(12.5%对3.9%,P<0.01)。13例糖尿病肾病患者中,9例(69.2%)在HD开始后36个月内发生CH;14例慢性肾小球肾炎患者中,11例(78.6%)在36个月后发生CH。6例患者(15.0%)在一次HD治疗后6小时内发生CH。我们比较了35例CH患者和一个年龄、性别、基础肾病、HD开始年龄及HD持续时间相匹配的对照组(66例患者)的实验室检查值、仰卧位血压和心电图(ECG)结果。数据在CH首次发作前3至4个月HD前后获取。CH组HD前后的收缩压和舒张压(SBP、DBP)显著高于对照组(HD前SBP:171±22.5对154±19.3mmHg,P<0.001;HD前DBP:89±13.6对81±9.6mmHg,P<0.001)。CH组左心室肥厚的发生率更高,Kt/V显著更低(1.23±0.26对1.38±0.34,P<0.05)。然而,两组间血清白蛋白和胆固醇水平或HD治疗期间肝素总剂量无显著差异。总之,维持性HD患者CH的发生率高,预后差。可逆性危险因素包括高血压以及可能的HD处方量,但不包括肝素抗凝。